Chu-Tian Mai

811 total citations
15 papers, 628 citations indexed

About

Chu-Tian Mai is a scholar working on Molecular Biology, Pharmacology and Rheumatology. According to data from OpenAlex, Chu-Tian Mai has authored 15 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Rheumatology. Recurrent topics in Chu-Tian Mai's work include Pharmacological Effects of Natural Compounds (3 papers), Hepatitis C virus research (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Chu-Tian Mai is often cited by papers focused on Pharmacological Effects of Natural Compounds (3 papers), Hepatitis C virus research (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Chu-Tian Mai collaborates with scholars based in China, Macao and United States. Chu-Tian Mai's co-authors include Chunli Wang, Meimei Wu, Ying Xie, Xiaojun Zhang, Ziren Su, Yuanyuan Cheng, Tiantian Wang, Xiaojun Zhang, Liang Liu and Hua Zhou and has published in prestigious journals such as Life Sciences, Pharmacological Research and Molecular Immunology.

In The Last Decade

Chu-Tian Mai

15 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chu-Tian Mai China 11 354 169 99 92 74 15 628
Weilian Bao China 14 294 0.8× 82 0.5× 56 0.6× 113 1.2× 68 0.9× 26 523
Panpan Liu China 12 303 0.9× 205 1.2× 46 0.5× 60 0.7× 70 0.9× 27 651
Xiaolin Xiao China 17 377 1.1× 152 0.9× 87 0.9× 106 1.2× 50 0.7× 34 844
Prajjal K. Singha United States 14 521 1.5× 83 0.5× 99 1.0× 77 0.8× 100 1.4× 19 1.1k
Qingqing Zhu China 15 339 1.0× 245 1.4× 122 1.2× 73 0.8× 58 0.8× 29 879
Changqing Zheng China 14 327 0.9× 114 0.7× 79 0.8× 88 1.0× 48 0.6× 29 695
Zirui Wan China 17 233 0.7× 78 0.5× 51 0.5× 158 1.7× 93 1.3× 30 647
Na Young Ko South Korea 15 331 0.9× 236 1.4× 97 1.0× 66 0.7× 60 0.8× 32 828
Ting Jiang China 13 271 0.8× 81 0.5× 46 0.5× 94 1.0× 84 1.1× 30 673

Countries citing papers authored by Chu-Tian Mai

Since Specialization
Citations

This map shows the geographic impact of Chu-Tian Mai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu-Tian Mai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu-Tian Mai more than expected).

Fields of papers citing papers by Chu-Tian Mai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chu-Tian Mai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu-Tian Mai. The network helps show where Chu-Tian Mai may publish in the future.

Co-authorship network of co-authors of Chu-Tian Mai

This figure shows the co-authorship network connecting the top 25 collaborators of Chu-Tian Mai. A scholar is included among the top collaborators of Chu-Tian Mai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chu-Tian Mai. Chu-Tian Mai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Zheng, De-Chong, et al.. (2024). Liver X receptor inverse agonist SR9243 attenuates rheumatoid arthritis via modulating glycolytic metabolism of macrophages. Acta Pharmacologica Sinica. 45(11). 2354–2365. 8 indexed citations
3.
4.
Xie, Ying, Chu-Tian Mai, De-Chong Zheng, et al.. (2021). Wutou decoction ameliorates experimental rheumatoid arthritis via regulating NF-kB and Nrf2: Integrating efficacy-oriented compatibility of traditional Chinese medicine. Phytomedicine. 85. 153522–153522. 50 indexed citations
5.
Wang, Xiaolin, De-Chong Zheng, Chu-Tian Mai, et al.. (2021). Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system. Acta Pharmacologica Sinica. 43(8). 2094–2108. 16 indexed citations
6.
Wu, Meimei, et al.. (2021). Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharmacological Research. 172. 105796–105796. 166 indexed citations
7.
Mai, Chu-Tian, De-Chong Zheng, Xinzhi Li, Hua Zhou, & Ying Xie. (2021). Liver X receptors conserve the therapeutic target potential for the treatment of rheumatoid arthritis. Pharmacological Research. 170. 105747–105747. 6 indexed citations
8.
He, Yufei, Chu-Tian Mai, Hudan Pan, et al.. (2021). Targeting immunometabolism by active ingredients derived from traditional Chinese medicines for treatment of rheumatoid arthritis. Chinese Herbal Medicines. 13(4). 451–460. 17 indexed citations
9.
Mai, Chu-Tian, et al.. (2021). Bile acids as regulatory molecules and potential targets in metabolic diseases. Life Sciences. 287. 120152–120152. 29 indexed citations
10.
Shan, Xiaoxiao, Caiyun Zhang, Chu-Tian Mai, et al.. (2021). The Biogenesis, Biological Functions, and Applications of Macrophage-Derived Exosomes. Frontiers in Molecular Biosciences. 8. 715461–715461. 54 indexed citations
11.
Liang, Tu-Liang, Runze Li, Chu-Tian Mai, et al.. (2021). A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy. Phytomedicine. 96. 153831–153831. 7 indexed citations
12.
Xie, Ying, Senling Feng, Chu-Tian Mai, et al.. (2020). Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism. Phytomedicine. 80. 153339–153339. 25 indexed citations
13.
He, Yufei, Chu-Tian Mai, Hudan Pan, et al.. (2020). The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis. Pharmacological Research. 161. 105134–105134. 21 indexed citations
14.
Wu, Meimei, Chunli Wang, Chu-Tian Mai, et al.. (2019). Flavonoids from Livistona chinensis fruit ameliorates LPS/D-GalN-induced acute liver injury by inhibiting oxidative stress and inflammation. Journal of Functional Foods. 61. 103460–103460. 23 indexed citations
15.
Mai, Chu-Tian, Meimei Wu, Chunli Wang, et al.. (2018). Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation. Molecular Immunology. 105. 76–85. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weilian Bao Breakdown of academic impact, for papers by Panpan Liu Breakdown of academic impact, for papers by Xiaolin Xiao Breakdown of academic impact, for papers by Prajjal K. Singha Breakdown of academic impact, for papers by Qingqing Zhu Breakdown of academic impact, for papers by Changqing Zheng Breakdown of academic impact, for papers by Zirui Wan Breakdown of academic impact, for papers by Na Young Ko Breakdown of academic impact, for papers by Ting Jiang
Rankless by CCL
2026